Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psychobiotics Ameliorate Anxiety and Depression Status in Patients Under Chemotherapy for Gastrointestinal Malignancies

NCT06496438 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT06496438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06496438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psychobiotics Ameliorate Anxiety and Depression Status in Patients Under Chemotherapy for Gastrointestinal Malignancies
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Not applicable
Overall status
Unknown status
Start date
November 15, 2023
Completion date
March 15, 2025
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorder, chemotherapy, depression, gastrointestinal cancer, probiotics, quality of life